
Lenacapavir’s near-100% HIV prevention hits a wall: Brazil can’t get a deal
Twice-yearly shots work in trials, but price, supply, and regulatory status turn rollout into a geopolitical fight.
By Khalid Al-Harbi·· 4 min

Curating from trusted global sources…
1 briefing · “lenacapavir”

Twice-yearly shots work in trials, but price, supply, and regulatory status turn rollout into a geopolitical fight.